ArticleMolecular and clinical oncology2018

Secondary cytoreductive surgery potentially improves the oncological outcomes of patients with recurrent uterine sarcomas.

Kenichi Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.